Patent · US Active

Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample

US9779204B2 · kind B2 · utility

4Cited by
7References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 29, 2015
Grant dateOct 3, 2017
Priority date
Expiry dateApr 4, 2036

Classification

  • Technology area (CPC H)Electricity
  • CPC primaryH01J49/0036
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A programmed computer functioning as a classifier operates on mass spectral data obtained from a blood-based patient sample to predict indolence or aggressiveness of prostate cancer. Methods of generating the classifier and conducting a test on a blood-based sample from a prostate cancer patient using the classifier are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.